Targeted Molecular Treatments in Non-Small Cell Lung Cancer: A Clinical Guide for Oncologists

Targeted Molecular Treatments in Non-Small Cell Lung Cancer: A Clinical Guide for Oncologists

Targeted molecular treatments have changed the way non-small cell lung cancer (NSCLC) is managed. Epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), v-raf murine sarcoma viral oncogene homolog B1 (BRAF), and c-ros oncogene 1 (ROS1) mutations are now used to guide specific ant...

Full description

Bibliographic Details
Main Authors: Kim Tam Bui, Wendy A. Cooper, Steven Kao, Michael Boyer
Format: Article
Language:English
Published: MDPI AG 2018-07-01
Series:Journal of Clinical Medicine
Subjects:
personalized therapy
non-small cell
lung cancer
targeted therapy
mutation
rearrangement
Online Access:http://www.mdpi.com/2077-0383/7/8/192

Internet

http://www.mdpi.com/2077-0383/7/8/192

Similar Items